JPRN-C000000193已完成3 期
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF) - Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 1,100 人开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active co-existing malignancy (synchronous or metachronous malignancy whose disease free period is within 5 years). Carcinoma in situ is eligible. 2) Severe postoperative complicatoins which do not resolve until registration. 3) There is following complicaion. insulin-controlling or uncontrollable diabetes mellitus, uncontrollable hypertension, myocardial infarction within six month or unstable angina pactoris, liver cirrhosis, interstitial pneumonia, pulmonary fibrosis, severe emphysema 4) Pregnant or breast-feeding woman. 5) Difficult to participate with the trial, having mentel disorder or psychiatric symptoms. 6) Judged to be inappropriate to register.
研究者
相似试验
已完成
3 期
Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)Patients with cervical cancerJPRN-C000000194Japan Clinical Oncology Group(JCOG)200
已完成
3 期
A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)extensive-disease small cell lung cancerJPRN-UMIN000000720Japan Clinical Oncology Group(JCOG)282
已完成
3 期
A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)uterine cervical neoplasmsJPRN-C000000335Japan Clinical Oncology Group(JCOG)250
已完成
2 期
A Randomized PhaseII/III Study of Concurrent Chemoradiotherapy with Low Dose Cisplatin plus 5-FU versus Concurrent Chemoraiotherapy with Standard Dose Cisplatin plus 5-FU for Locally Advanced Unresetable Esophageal Cancer in the Thorax.(JCOG0303)ocally advanced unresectable esophageal cancer in the thoraxJPRN-UMIN000000861Japan Clinical Oncology Group(JCOG)364
已完成
3 期
Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)Patients with Metatatic Breast CancerJPRN-C000000179Japan Clinical Oncology Group(JCOG)450